BTTX OTC
Better Therapeutics, Inc.
1W: -0.0%
1M: +0.0%
3M: +0.0%
YTD: -0.0%
1Y: -0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$3M
-68.6% ▼
Operating Income
-$38M
-25.2% ▼
Net Income
-$40M
+1.4% ▲
EPS (Diluted)
$-1.69
+1.2% ▲
EBITDA
-$38M
+1.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
| Revenue | $18K | $8K | $0 | $0 |
| YoY Growth | +0.0% | -55.6% | -100.0% | +0.0% |
| Cost of Revenue | $898K | $682K | $2M | $3M |
| Gross Profit | -$880K | -$674K | -$2M | -$3M |
| Gross Margin | -4888.9% | -8425.0% | — | — |
| R&D Expenses | $2M | $3M | $19M | $16M |
| SG&A Expenses | $3M | $3M | $11M | $22M |
| Operating Expenses | $5M | $6M | $29M | $36M |
| Operating Income | -$6M | -$6M | -$31M | -$38M |
| Operating Margin | -32072.2% | -79037.5% | — | — |
| Interest Expense | $11K | $100K | $185K | $1M |
| Income Before Tax | -$6M | -$6M | -$40M | -$40M |
| Tax Expense | $0 | $153K | -$153K | $7K |
| Net Income | -$6M | -$6M | -$40M | -$40M |
| Net Margin | -32194.4% | -79837.5% | — | — |
| EPS (Diluted) | $-0.25 | $-1.04 | $-1.71 | $-1.69 |
| EBITDA | -$6M | -$6M | -$39M | -$38M |
| Shares Outstanding | 24M | 8M | 24M | 24M |